Immunomodulation in Cystic Fibrosis: Why and How?

Cystic fibrosis (CF) lung disease is characterized by unconventional mechanisms of inflammation, implicating a chronic immune response dominated by innate immune cells. Historically, therapeutic development has focused on the mutated cystic fibrosis transmembrane conductance regulator (CFTR), leadin...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacalone, Vincent D., Dobosh, Brian S., Gaggar, Amit, Tirouvanziam, Rabindra, Margaroli, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247557/
https://www.ncbi.nlm.nih.gov/pubmed/32397175
http://dx.doi.org/10.3390/ijms21093331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247557/
https://www.ncbi.nlm.nih.gov/pubmed/32397175
http://dx.doi.org/10.3390/ijms21093331

Ejemplares similares